NCT00932139 Effect of Electro-Acupuncture on Blood Pressure
| NCT ID | NCT00932139 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2003-02 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2003-02 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Based on previous published research in animals and human, the investigators hypothesize that electroacupuncture (EA) will have a positive effect on hypertension.
Eligibility Criteria
Inclusion Criteria: * Patients with mild coronary disease, and no significant ECG change reflecting ischemia at rest. * Patients with high blood pressure with or without antihypertensive medication. Exclusion Criteria: * Pregnant or nursing women * Individuals with severe coronary disease (continuous angina) * Conduction abnormalities on ECG consistent with left bundle branch block * Cardiac arrhythmias associated with low blood pressure (90 mmHg) * Peripheral vascular disease * Orthopedic disease * Diabetic or psychological illness that could interfere with safe performance of exercise of psychophysiological stress testing * Those with known sensitivity to topical preparations or strong reactions to medical dressings and skin tapes
Contact & Investigator
Shaista Malik, MD, PhD, MPH
PRINCIPAL INVESTIGATOR
University of California, Irvine
Frequently Asked Questions
Who can join the NCT00932139 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00932139 currently recruiting?
Yes, NCT00932139 is actively recruiting participants. Contact the research team at stjenalo@uci.edu for enrollment information.
Where is the NCT00932139 trial being conducted?
This trial is being conducted at Irvine, United States, Orange, United States.
Who is sponsoring the NCT00932139 clinical trial?
NCT00932139 is sponsored by University of California, Irvine. The principal investigator is Shaista Malik, MD, PhD, MPH at University of California, Irvine. The trial plans to enroll 160 participants.